Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children
- PMID: 19171632
- PMCID: PMC3774269
- DOI: 10.1542/peds.2008-0596
Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children
Abstract
Objectives: Early transition from intravenous to oral antimicrobial therapy for acute osteomyelitis in children has been suggested as a safe and effective alternative to traditional prolonged intravenous therapy via central venous catheter, but no studies have directly compared these 2 treatment modalities. We sought to compare the effectiveness of early transition from intravenous to oral antimicrobial therapy versus prolonged intravenous antimicrobial therapy for the treatment of children with acute osteomyelitis.
Methods: We conducted a retrospective cohort study of children aged 2 months to 17 years diagnosed with acute osteomyelitis between 2000 and 2005 at 29 freestanding children's hospitals in the United States to confirm the extent of variation in the use of early transition to oral therapy. We used propensity scores to adjust for potential differences between children treated with prolonged intravenous therapy and logistic regression to model the association of outcome (treatment failure rates within 6 months of diagnosis) and difference in the mode of therapy within hospitals and across hospitals.
Results: Of the 1969 children who met inclusion criteria, 1021 received prolonged intravenous therapy and 948 received oral therapy. The use of prolonged intravenous therapy varied significantly across hospitals (10%-95%). The treatment failure rate was 5% (54 of 1021) in the prolonged intravenous therapy group and 4% (38 of 948) in the oral therapy group. There was no significant association between treatment failure and the mode of antimicrobial therapy. Thirty-five (3.4%) children in the prolonged intravenous therapy group were readmitted for a catheter-associated complication.
Conclusions: Treatment of acute osteomyelitis with early transition to oral therapy is not associated with a higher risk of treatment failures and avoids the risks of prolonged intravenous therapy through central venous catheters.
Conflict of interest statement
Potential conflicts of interest: All authors report no conflicts of interest relevant to this article.
Figures
Similar articles
-
Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children.JAMA Pediatr. 2015 Feb;169(2):120-8. doi: 10.1001/jamapediatrics.2014.2822. JAMA Pediatr. 2015. PMID: 25506733
-
Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis.Pediatrics. 2006 Apr;117(4):1210-5. doi: 10.1542/peds.2005-1465. Pediatrics. 2006. PMID: 16585317
-
Intravenous versus oral outpatient antibiotic therapy for pediatric acute osteomyelitis.Iowa Orthop J. 2013;33:208-12. Iowa Orthop J. 2013. PMID: 24027485 Free PMC article.
-
For Children Discharged after Hospitalization for Serious Bacterial Infections, Are Orally Administered Antibiotics as Effective as Antibiotics Given Intravenously through a PICC? [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Nov. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2018 Nov. PMID: 38117920 Free Books & Documents. Review.
-
Systematic review of duration and choice of systemic antibiotic therapy for acute haematogenous bacterial osteomyelitis in children.J Paediatr Child Health. 2013 Sep;49(9):760-8. doi: 10.1111/jpc.12251. Epub 2013 Jun 9. J Paediatr Child Health. 2013. PMID: 23745943 Review.
Cited by
-
Developing a nomogram for predicting acute complicated course in pediatric acute hematogenous osteomyelitis.Ital J Pediatr. 2024 Jul 29;50(1):130. doi: 10.1186/s13052-024-01703-z. Ital J Pediatr. 2024. PMID: 39075514 Free PMC article.
-
[Arthritis and osteomyelitis in childhood and adolescence-Bacterial and nonbacterial].Z Rheumatol. 2024 Apr 23. doi: 10.1007/s00393-024-01504-z. Online ahead of print. Z Rheumatol. 2024. PMID: 38653784 German.
-
First-Generation Cephalosporins for Treatment of Acute Hematogenous Osteomyelitis in Children: A Study of Efficacy and Adverse Effects.Open Forum Infect Dis. 2023 Dec 14;10(12):ofad610. doi: 10.1093/ofid/ofad610. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38156049 Free PMC article.
-
Impact of guidelines implementation on empiric antibiotic treatment for pediatric uncomplicated osteomyelitis and septic arthritis over a ten-year period: Results of the ELECTRIC study (ostEomyeLitis and sEptiC arThritis tReatment in children).Front Pediatr. 2023 Feb 23;11:1135319. doi: 10.3389/fped.2023.1135319. eCollection 2023. Front Pediatr. 2023. PMID: 36911022 Free PMC article.
-
Defining Variability in Evaluation and Management of Children with Chronic Osteomyelitis.J Pediatric Infect Dis Soc. 2023 Apr 28;12(4):226-229. doi: 10.1093/jpids/piad007. J Pediatric Infect Dis Soc. 2023. PMID: 36688512 Free PMC article.
References
-
- Vasquez M. Osteomyelitis in children. Current Opinion in Pediatrics. 2002;14:112–115. - PubMed
-
- Sonnen GM, Henry NK. Pediatric bone and joint infections. Diagnosis and antimicrobial management. Pediatr Clin North Am. 1996 Aug;43(4):933–947. - PubMed
-
- Tetzlaff TR, McCracken GH, Jr, Nelson JD. Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr. 1978 Mar;92(3):485–490. - PubMed
-
- Walker SH. Staphylococcal osteomyelitis in children. Success with cephaloridine-cephalexin therapy. Clin Pediatr (Phila) 1973 Feb;12(2):98–100. - PubMed
-
- Kolyvas E, Ahronheim G, Marks MI, Gledhill R, Owen H, Rosenthall L. Oral antibiotic therapy of skeletal infections in children. Pediatrics. 1980 May;65(5):867–871. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
